Current Report Filing (8-k)
20 12월 2018 - 4:07AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
t
he
Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported):
December
19, 2018
USANA HEALTH
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Utah
(State
or other jurisdiction of incorporation)
001-35024
|
|
87-0500306
|
(Commission File No.)
|
|
(IRS Employer Identification
|
|
|
Number)
|
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
|
(Address
of principal executive offices,
Zip
Code)
|
Registrant’s
telephone number, including area code:
(801)
954-7100
|
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
⃞
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17
CFR §240.12b-2).
|
⃞
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
|
Item 5.02.
|
|
Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.
|
Effective as of December 19, 2018, the Board of Directors of USANA
Health Sciences, Inc. (the “Company”) acted unanimously to appoint Ms.
Peggie Pelosi as an additional director of the Company, for an initial
term expiring at the Company’s 2019 Annual Meeting of Shareholders. Ms.
Pelosi has not been appointed to any Committees of the Board of
Directors at this time.
Ms. Pelosi is a corporate social responsibility/sustainability
practitioner. Since 2005, Ms. Pelosi has been the founding partner and
strategic advisor at Orenda Connections, a corporate social
responsibility consultancy in Toronto, Ontario, Canada. She is also an
Instructor in the Certificate Program in corporate social responsibility
at the University of St. Michael's College in the University of Toronto,
and a part-time professor in sustainable business management post
graduate studies at Seneca College, Faculty of Business in Toronto.
Since 2015, she has also served as the Executive Director of Innovators
Alliance, a network of CEO’s focused on sustainable and profitable
growth through innovation.
Prior to her career and academic work in corporate social responsibility
and sustainability, Ms. Pelosi served as a member of the Company’s
management team, first as Executive Director of Sales for Canada and
then as Vice President of Network Development. She worked for the
Company until 2004. While at the Company, Ms. Pelosi began the program
that would evolve into the USANA True Health Foundation, and this led to
her interest in corporate social responsibility. Prior to her roles at
the Company, Ms. Pelosi had 15 years of direct selling leadership
experience. Ms. Pelosi has also previously served on the Board of
Directors of a number on non-profit organizations including the
Children’s Hunger Fund and Big Brothers Big Sisters of Toronto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
USANA HEALTH SCIENCES, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ G. Douglas Hekking
|
|
|
|
|
G. Douglas Hekking, Chief Financial Officer
|
|
|
|
|
|
|
|
|
|
|
Date:
|
December 19, 2018
|
|
|
|
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024